Tap either name to swap in any company, coin or metal, and everything below updates as you pick.
One enGene Therapeutics share would cost
$25,988.52
$1.74T spread across 67M enGene Therapeutics shares.
This holds the unit count fixed and moves only the valuation, which is what makes it a clean illustration of relative size. It is not a forecast, a target, or a claim that either outcome is possible: assets of very different kinds rarely end up worth the same.